Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 20, 2022

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide in Participants With Prediabetes

Diabetes Care

 

Additional Info

Diabetes Care
Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
Diabetes Care 2022 Jun 20;[EPub Ahead of Print], L Perreault, M Davies, JP Frias, PN Laursen, I Lingvay, S Machineni, A Varbo, JPH Wilding, SOR Wallenstein, CW le Roux

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading